In summary, compared with unmodified MC3-siYT,CD44 peptide-modifiedAKPC-siYT induced enhanced gene silencing and antitumor efficacy inzebrafish breast cancer cell xenografts with a good safety profile. This evidence concerns the gene CD44 and breast carcinoma.